Better purification process development. Faster to market.

View this email in your browser

BIA Separations is now part of Sartorius Stedim Biotech. Learn more >

More than 20 years of hands-on experience with the most challenging biopharmaceutical products has provided us with a unique foundation to offer expert-level process development services.

We can support you with process development of AAV, mRNA, pDNA and other large biomolecules, analytical method development, or preparation of custom purification media with your ligand of choice.

Collaboration with AveXis led to the first licensed AAV therapeutic in the world. It took just 15 months from laboratory to manufacturing!

“We are especially grateful that BIA Separations shared, and operated, with the same sense of urgency we did to help bring gene therapy to the SMA community. BIA’s experience with AAV purification and its chromatographic technology were important contributions and we look forward to our continued work together.”

Andy Stober,
Former Senior Vice President of Technical Operations for AveXis

BIA Separations welcomes a new specialized expert to the team

We are happy to announce that we welcomed a new team member: Rok Sekirnik, PhD was appointed as Head of Process Development mRNA/pDNA at the beginning of this year. His new role is leading a team that focuses on providing new solutions to the current challenges in mRNA manufacturing.

Have your Process Developed in 4 simple steps.

Contact us; we have all the right tools and expertise to help you develop your downstream process in just few months!